News from all angles
(MedPage Today) -- Patients taking GLP-1 receptor agonists (GLP-1RAs) had a lower likelihood of developing age-related macular degeneration (AMD) compared with patients using other glucose-lowering m…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network